Transforming respiratory diseases management: a CMO-based hospital pharmaceutical care model. [PDF]
Zarate-Tamames B+7 more
europepmc +1 more source
PHP16 PATIENT SATISFACTION AND PHARMACEUTICAL OUTPATIENT CARE
Christine Huttin
openalex +1 more source
Pharmaceutical care services: a systematic review of published studies, 1990 to 2003, examining effectiveness in improving patient outcomes [PDF]
Elizabeth E. Roughead+2 more
openalex +1 more source
Advanced Oral Delivery Systems for Nutraceuticals
Emerging delivery technologies are explored to overcome barriers to oral nutraceutical absorption. Traditional carriers are compared with novel platforms including biodegradable polymers, MOFs, MPNs, and 3D printing. These systems enhance bioavailability, control release, and enable personalized nutrition.
Xin Yang+4 more
wiley +1 more source
Evidence-Based Pharmaceutical Care in Community Pharmacies: A Survey of 595 French Pharmacists. [PDF]
Bosson L+6 more
europepmc +1 more source
An Attempt of Team Medical Treatment by Pharmaceutical Care in Surgical Wards.
Shigefumi Morimoto+5 more
openalex +2 more sources
Membrane fusion‐inspired nanomaterials offer transformative potential in diagnostics by mimicking natural fusion processes to achieve highly sensitive and specific detection of disease biomarkers. This review highlights recent advancements in nanomaterial functionalization strategies, signal amplification systems, and stimuli‐responsive fusion designs,
Sojeong Lee+9 more
wiley +1 more source
Exploring the Significance of Pharmaceutical Care in Mental Health: A Spotlight on Cannabis. [PDF]
da Costa-Oliveira C+5 more
europepmc +1 more source
Evaluation of pharmaceutical care services in the Middle East Countries: a review of studies of 2013-2020. [PDF]
Sallom H, Abdi A, Halboup AM, Başgut B.
europepmc +1 more source
Microphysiological Systems for Comorbidity Studies: Chronic Kidney Disease and Osteoarthritis
This review highlights the potential of organ‐on‐a‐chip systems for studying comorbidities, using chronic kidney disease (CKD) and osteoarthritis (OA) as examples. It summarizes recent advances in kidney‐on‐a‐chip and joint‐on‐a‐chip models and discusses their current and potential application in investigating CKD, OA, and CKD‐OA comorbidity, aiming to
Mingying Han+7 more
wiley +1 more source